Has Joel Wells, MD received payments from drug or device companies?

Yes. Drug and device makers reported $102,898 in general payments to Joel Wells, MD across 94 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joel Wells, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joel Wells, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joel Wells, MD

Adult Reconstructive Orthopaedic Surgery · Dallas, TXNPI 1316268659

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $95,261 of the $102,898 with a category attached, or 92.6%. Medical Device Business Services, Inc. accounts for 61.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $31,287 and has fallen 93.1% since, to $2,153 in 2025.

$102,898in general payments, 2019–2025

Across 94 payments — averaging $1094.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$63K
Johnson & Johnson$37K
Stryker$1K
Pylant Medical$1K
Smith+Nephew$63
Pacira Pharmaceuticals Incorporated$13

What the payments were for

Consulting fees$95,26193%
Travel & lodging$3,2423%
Food & beverage$3,1963%
Education$1,2001%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	46	$63,336
Johnson & Johnson(3 entities)	26	$37,019
Stryker	18	$1,267
Pylant Medical	1	$1,200
Smith+Nephew	2	$63
Pacira Pharmaceuticals Incorporated	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$102,898 in reported general payments places this provider in the 80th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$81,723

Medicare patients

167

Services billed

343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	19	$374
Mupirocin	41	$285
Doxycycline Monohydrate	21	$283
Oxycodone Hcl	47	$104
Hydroxyzine Pamoate	14	$45

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Dallas

Antonia ChenDallas$3.8M
Donald HohmanDallas$537K
Bilal MahmoodDallas$33K
Justin CardenasDallas$29K
Tyler YoungmanDallas$8K
Andrew ChambersDallas$8K
Tyler GoldbergAustin$4.6M
John BarringtonPlano$2.2M
Roger EmersonPlano$691K
Steven WeedenFort Worth$370K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →